Task: Answer the multiple-choice question.
Question: Which drug has a 17.175% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) N#CC(C(=O)OC1CCCCC1)c1nc2ccccc2nc1N1CCOCC1
b.) CC(=O)Nc1cccc(NC(=O)c2ccccc2OCc2ccccc2)c1
c.) NC(=S)Nc1cccc(-c2n[nH]c(=S)o2)c1
Answer: c. NC(=S)Nc1cccc(-c2n[nH]c(=S)o2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NC(=S)Nc1cccc(-c2n[nH]c(=S)o2)c1
NC(=S)Nc1cccc(-c2n[nH]c(=S)o2)c1
[3-(2-sulfanylidene-3H-1,3,4-oxadiazol-5-yl)phenyl]thiourea